Home > News > KU Researcher Receives Prestigious Alfred P. Sloan Fellowship
June 5th, 2007
KU Researcher Receives Prestigious Alfred P. Sloan Fellowship
Abstract:
Im's research could have applications in nanotechnology and pharmaceuticals.
"The aim of our work is to understand human disease at the molecular level," said Im. "If you look at the drugs that we're using now, about 50 percent of commercial drugs are targeting membrane proteins. As our research progresses, we hope to help make a map to develop the drugs of the future."
A committee of researchers reviews more than 500 nominations each year to determine a final selection of 116 Sloan fellows in seven scientific fields.
Source:
infozine.com
| Related News Press |
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
Rice membrane extracts lithium from brines with greater speed, less waste October 3rd, 2025
Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025
Next-generation quantum communication October 3rd, 2025
"Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025
Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records
Researchers tackle the memory bottleneck stalling quantum computing October 3rd, 2025
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024
|
|
||
|
|
||
| The latest news from around the world, FREE | ||
|
|
||
|
|
||
| Premium Products | ||
|
|
||
|
Only the news you want to read!
Learn More |
||
|
|
||
|
Full-service, expert consulting
Learn More |
||
|
|
||